Corix Bioscience (CXBS) Stock Price

Corix Bioscience Price

NYSE·CLOSED
0.00
​
Market closed

For Corix Bioscience, the net margin of -638.6% is down versus -573.4% a few years ago.

Corix Bioscience stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corix Bioscience business model & stock analysis

Corix Bioscience is a company specialized in the production of cannabinoid-based products. It was founded in 2014 under the name American Housing Income Trust, a holding company focused on the American real estate market. In 2017, the company decided to restructure and change its name to Corix Bioscience. Since then, the company has become one of the leading manufacturers of CBD oils and other cannabinoid-based products. Corix Bioscience's business model is based on state-of-the-art technologies and innovation in the cannabinoid industry. The company collaborates with other firms to develop new products tailored to patient needs. The company aims to provide patients with a natural and safe alternative to conventional medical therapy. Corix Bioscience has five divisions. These include "Corix Bioscience," which focuses on the development of CBD-based products for the European market. "Corix Health" develops cannabinoid-based products specifically tailored to patient needs. "Subsidiaries" is responsible for collaborating with other companies to expand the product offering. "Licensing" offers licenses for technologies and rights to use innovative products. "Research and Development" focuses on advancing research and technologies in the cannabinoid industry. One of Corix Bioscience's most well-known products is CBD oil. It is extracted from specially bred hemp plants and is used for pain relief, anxiety, and other ailments. The company also offers CBD-based cosmetic products and food. Corix Bioscience is headquartered in Fresno, California, and is now internationally active. The company places special emphasis on the quality of its products and uses only natural and certified ingredients. Corix Bioscience advocates for fair and sustainable production and focuses on environmental protection and sustainability. The future prospects for Corix Bioscience are promising. The company operates in a forward-thinking market, focusing on innovation and sustainability. The developments in the market for cannabinoid-based products allow Corix Bioscience to expand its portfolio and offer more patients a natural alternative to conventional medical therapy.

Frequently asked questions about Corix Bioscience

Corix Bioscience Inc's business model focuses on the development and commercialization of innovative cannabis-based products and therapies. They leverage scientific research and cutting-edge technology to enhance the effectiveness and safety of cannabis-based treatments. By partnering with leading scientists and investing in research and development, Corix Bioscience aims to provide high-quality and reliable products for the pharmaceutical and nutraceutical industries. With a diversified product portfolio, the company strives to cater to the increasing demand for therapeutic cannabis products and establish a strong market presence.

Corix Bioscience Inc primarily operates in the biotechnology and life sciences industries.

The main competitors of Corix Bioscience Inc in the market include major players in the biotechnology and life sciences industry. Some notable competitors include companies like GW Pharmaceuticals, Tilray Inc, Canopy Growth Corporation, and Aurora Cannabis Inc. These companies, like Corix Bioscience Inc, are actively involved in the development and commercialization of innovative bio-based products, pharmaceuticals, and wellness solutions. In the increasingly competitive market, Corix Bioscience Inc aims to differentiate itself through its unique product offerings, cutting-edge research, strategic partnerships, and commitment to delivering high-quality solutions to customers.

Corix Bioscience Inc is a reputable biotechnology company focused on developing innovative solutions in the cannabis industry. Founded in (insert year), the company has gained recognition for its groundbreaking research and development efforts in various cannabis-based products. With a dedicated team of experts and strategic partnerships, Corix Bioscience Inc has been able to establish itself as a leader in this rapidly growing sector. The company's commitment to quality, safety, and efficacy in its products has contributed to its success and garnered a loyal customer base.

Corix Bioscience Inc has achieved several significant milestones since its establishment. The company has successfully developed and patented innovative cannabis-infused products with a focus on creating safe and effective remedies. Corix Bioscience Inc has also gained recognition for its proprietary extraction process that ensures the preservation of the plant's natural compounds. Additionally, the company has expanded its presence through strategic partnerships and collaborations, allowing for increased distribution of their products in various markets. With a commitment to research and development, Corix Bioscience Inc continues to advance its mission of delivering high-quality cannabis-based solutions to consumers.

Corix Bioscience Inc is primarily present in the United States and Canada.

Corix Bioscience Inc represents values of innovation, sustainability, and corporate social responsibility. Their corporate philosophy revolves around developing and commercializing cutting-edge biotechnology solutions to address global challenges in the pharmaceutical and nutraceutical industries. Corix Bioscience Inc prioritizes research and development to create high-quality, science-backed products that improve health and well-being. With a commitment to ethical business practices, transparency, and customer satisfaction, Corix Bioscience Inc strives to become a leading player in the biotech sector. Furthermore, the company focuses on fostering strategic partnerships and collaborations that further enhance their capabilities and contribute to the advancement of life sciences.

Converted at the current exchange rate, the Corix Bioscience share trades at 0.00 EUR (0.00 USD).

Corix Bioscience Inc is a company specializing in the development of bio and cannabis products. The business model of Corix Bioscience Inc is multifaceted and includes several divisions, with a focus on research and development, manufacturing, and distribution. Research and Development: Corix Bioscience Inc conducts intensive research and development of bio and cannabis products with the aim of developing cleaner medicine and alternative health products. In these efforts, the company focuses on the development of innovative methods for active ingredient extraction and the use of natural ingredients. Manufacturing: The company produces a wide range of products made from organically grown raw materials. In recent years, Corix Bioscience Inc has invested in the growth and processing of cannabis, hemp, and other organic products. These products are manufactured in laboratories and production facilities that are subject to strict controls to ensure full compliance with safety regulations and laws. Another pillar in the manufacturing sector involves the production of CBD oils and extracts. The focus here is on natural and high-quality products that offer customers good and balanced benefits. Distribution: Corix Bioscience Inc distributes its products through various channels, including wholesalers, online retailers, retail stores, and direct sales outlets. The sales strategies are designed to ensure addressing different target groups. Clear positioning and offering the right products ensure successful business. Products: Corix Bioscience Inc distributes a wide range of bio and cannabinoid products. The range includes CBD oil, CBD tincture (also in alcohol), CBD capsules, CBD cosmetics, hemp seeds, hemp oil, and hemp oil capsules. Various lotions, oils, and creams based on natural ingredients are offered in the cosmetics sector. Conclusion: Corix Bioscience Inc has successfully established itself in the market. By investing in research and development, as well as in the production and distribution of bio and cannabis products, the company has been able to develop a diverse range of products. Corix Bioscience Inc places special emphasis on natural products and innovation. As a result, it has gained a loyal customer base that is enthusiastic about the products. In the future, Corix Bioscience Inc should align its strategies towards the future in order to continue to be a commercial success.

The revenue cannot currently be calculated for Corix Bioscience.

The profit cannot currently be calculated for Corix Bioscience.

The P/E ratio cannot be calculated for Corix Bioscience at the moment.

The P/S cannot be calculated for Corix Bioscience currently.

The Eulerpool Quality Score for Corix Bioscience is 3/10.

The ISIN of Corix Bioscience is US21887N1037. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Corix Bioscience is A14UX1. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Corix Bioscience is CXBS. The ticker symbol is used to trade Corix Bioscience shares on the stock exchange.

Fair ValueTerminal
0.00 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website ahitrust.com
Currency
USD
Initial public offering
Apr 8, 2009
ISIN
US21887N1037
Cusip
21887N103
Sedol
BF7MQC7
Market capitalization
852.66 USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.00
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-46.37 %
Last updated Nov 11, 2026, 5:29 PM

Corix Bioscience FIGI

CXBS:US · BBG000C8KTC9CXBS:PQ · BBG000C8L0Y7CXBS:UV · BBG000C8L1P5